Effects of Hyperbaric Oxygen Therapy (HBOT) on the Male Endocrine System: A Scientific Review of Testosterone Synthesis and Leydig Cell Function

A Review Article on Hyperbaric Oxygen Therapy and the Male Endocrine System

Abstract

Testosterone, the principal androgen in men, is synthesized endogenously through processes that are highly dependent on mitochondrial function in Leydig cells, local microcirculatory conditions, and oxygen availability.[3,4,8] In recent years, as research into hyperbaric oxygen therapy (HBOT) has expanded in the fields of regenerative medicine and anti-aging, its potential effects on the male gonadal system and endocrine environment have gradually attracted academic attention.[9–11,15–17,19] This article aims to systematically review the biological mechanisms through which hyperbaric oxygen may influence testosterone synthesis, objectively compare consistent and conflicting findings in the existing clinical literature, and provide evidence-based technical references for wellness centers and related practitioners.

Research Background and Current Physiological Understanding

1. Male Aging: More Than a Decline in Hormone Levels

In conventional understanding, age-related androgen changes in men are often reduced to a single concept: declining testosterone. From a physiological perspective, however, the process is considerably more complex.

Epidemiological data indicate that total testosterone (TT) levels in men decline by approximately 1%–2% per year after the age of 30. Biologically active free testosterone declines even more significantly because sex hormone-binding globulin (SHBG) tends to increase with age.[1,2] However, this is only the observable outcome.

Behind this outcome are two deeper and frequently overlooked pathophysiological processes:

• Microvascular Decline: With increasing age, systemic capillary density decreases and endothelial function deteriorates, reducing the efficiency with which oxygen and nutrients are delivered to tissues.[3,4]
• Mitochondrial Dysfunction: Mitochondria serve as the cell’s “powerhouses.” A decline in oxidative phosphorylation efficiency directly affects all energy-intensive cellular activities—and testosterone synthesis is itself a highly energy-dependent process.[3,8]

2. The Hidden Suppressive Effect of Hypoxia on the Gonads

One fact that is receiving increasing attention in endocrinology is that testicular Leydig cells are highly sensitive to hypoxia.[5,6]

Leydig cells are responsible for producing more than 95% of the testosterone in the human body.[4] When local microcirculation deteriorates because of vascular degeneration, testicular tissue may enter a state of chronic, low-grade hypoxia. This hypoxic environment can inhibit the activity of steroidogenic enzymes through multiple pathways, thereby suppressing endogenous testosterone synthesis at its source.[5,6]

In other words, the challenge faced by many men may not simply be “aging of the hormone-producing glands,” but rather suppression of the synthetic pathway caused jointly by insufficient energy supply and impaired oxygen delivery.[3,5,6]

3. A Scientific Question Worth Exploring

Exogenous testosterone replacement therapy (TRT) is undoubtedly an effective clinical intervention. However, through negative feedback, TRT suppresses the hypothalamic–pituitary–gonadal axis, or HPG axis, and may further reduce the body’s endogenous testosterone-producing capacity.[7]

For this reason, the scientific community has continued to explore an important question:

Is there a non-pharmacological, non-invasive method that can support the body’s endogenous testosterone synthesis pathways by improving cellular energy metabolism and microcirculation?

Hyperbaric oxygen therapy is one of the candidate approaches that has entered the research field under this scientific premise.[9,15–17]

In-Depth Biological Mechanisms Through Which Hyperbaric Oxygen May Influence Testosterone Synthesis

To understand the potential effects of hyperbaric oxygen, it is necessary to return to the molecular basis of testosterone synthesis. The following three mechanistic pathways form the core of this discussion.

Mechanism 1: Mitochondrial ATP Production and Cholesterol Transport

The rate-limiting step in testosterone synthesis does not occur during enzymatic catalysis itself. Instead, it is the transport of cholesterol from the outer mitochondrial membrane to the inner mitochondrial membrane.[8]

This transport process depends heavily on two conditions:

1. An adequate supply of energy in the form of ATP;
2. Normal activity of the steroidogenic acute regulatory protein, or StAR protein.[3,8]

The StAR protein is responsible for “pumping” cholesterol to the inner mitochondrial membrane, where the CYP11A1 enzyme initiates the steroidogenic cascade.[3,4,8] The synthesis, folding, and functional maintenance of StAR are all energy-intensive processes. This means that the adequacy of mitochondrial energy supply directly determines the upper limit of testosterone synthesis efficiency.[3,8]

The core physical principle of hyperbaric oxygen therapy is that it reduces oxygen transport’s dependence on hemoglobin. In a pressure environment of 1.3 to 1.5 ATA, combined with the inhalation of high-concentration oxygen through a dedicated mask, Henry’s law indicates that the concentration of physically dissolved oxygen in plasma may increase severalfold.[9,18]

A rigorous technical clarification is necessary here: the substantial increase in dissolved oxygen results from the synergy between pressure and high-concentration oxygen inhalation, rather than from pressure alone. If pressure is increased to 1.3–1.5 ATA while the user continues to breathe ordinary air containing approximately 21% oxygen, the increase in dissolved plasma oxygen is very limited. The multiplication of dissolved oxygen described by Henry’s law becomes significant only when increased pressure is combined with the inhalation of high-concentration oxygen, such as oxygen at a concentration of 90%–95%.[9,18]

This is why a complete hyperbaric oxygen system must combine precise pressure control with high-concentration oxygen delivery through an oxygen concentrator and breathing mask, rather than relying on a pressurized chamber alone.

This dissolved oxygen, which is not constrained by the oxygen-binding capacity of hemoglobin, may diffuse beyond compromised microvascular pathways and reach Leydig cells at the distal ends of the microcirculation.[9]

Adequate oxygen supply → support for efficient mitochondrial oxidative phosphorylation → sustained ATP production → maintenance of StAR protein activity → support for the normal operation of endogenous testosterone synthesis pathways.

This represents a clear cellular energy pathway.[3,8]

Mechanism 2: Bidirectional Regulation of Oxidative Stress and HIF-1α Homeostasis

A common concern is whether exposure to high concentrations of oxygen generates excessive reactive oxygen species (ROS) and causes oxidative damage.

This concern is valid under conditions of continuous and prolonged hyperoxic exposure.[9,11,12] Modern research, however, has revealed a more nuanced phenomenon: the key issue is not simply the “dose of oxygen,” but the manner in which exposure occurs.[10–12]

Intermittent and periodic exposure to hyperbaric oxygen—for example, mild hyperbaric oxygen therapy lasting 60–90 minutes per session, followed by a return to normoxic conditions—may create a mechanism known as the hyperoxic-hypoxic paradox. It is also considered a representative example of hormesis.[10,11]

The core principle is intermittency:

• Continuous, uninterrupted hyperoxic exposure may cause ROS to accumulate persistently, eventually depleting antioxidant reserves and producing cellular damage.[9,11,12]
• By contrast, the pulsed ROS signals produced by alternating between oxygen exposure and a return to normal oxygen conditions may be recognized by the body as a form of beneficial stress. Instead of producing cumulative injury, these temporary signals may efficiently upregulate the body’s endogenous antioxidant defense systems.[10–12]

Activated endogenous antioxidant enzymes include:

• Superoxide dismutase (SOD)
• Glutathione peroxidase (GPx)
• Catalase[11,12]

Increased activity of these enzymes may help Leydig cells reduce their chronic oxidative stress burden over time. This reflects the principle that low-dose, intermittent stimulation may produce a protective adaptive response.[10–12]

Intermittent exposure is therefore not only a prerequisite for the proposed adaptive effects, but also an important safety mechanism for avoiding oxidative injury.

At the same time, by relieving chronic hypoxia in Leydig cells, hyperbaric oxygen therapy may help regulate excessive expression of hypoxia-inducible factor 1-alpha, or HIF-1α.[5,6] Persistently elevated HIF-1α under chronic hypoxic conditions may disrupt normal steroidogenesis and cellular homeostasis. Improved oxygen availability may help return this signaling pathway toward physiological levels, creating a healthier microenvironment for Leydig cells.[6]

Mechanism 3: Endothelial Function, Nitric Oxide, and Gonadal Microcirculation

The third mechanism returns to the issue of microvascular degeneration discussed at the beginning of this article.

Multiple studies have observed that hyperbaric oxygen therapy may promote the activity of endothelial nitric oxide synthase, or eNOS, thereby increasing the bioavailability of nitric oxide (NO).[11,13] NO is a key signaling molecule involved in vascular relaxation and endothelial health.

More importantly, periodic hyperbaric oxygen exposure has been proposed to stimulate angiogenesis by regulating signaling pathways involving vascular endothelial growth factor (VEGF) and promoting the formation of new capillaries.[9–11,14]

A healthy, dense vascular network has two important implications:

• For erectile function, adequate blood flow and NO availability form the physiological foundation of normal erection. This has been supported by several clinical studies examining HBOT and erectile function.[14,16]
• For the endocrine system, effective microcirculation is necessary for the efficient delivery of hormonal signals, oxygen, and nutrients throughout the gonadal system.[3,4]

In other words, improved microcirculation serves as the “infrastructure” required for the previously discussed mechanisms involving energy supply and oxidative regulation.

Clinical Research and Neutral Scientific Observations

Observation A: Supportive Findings

Some studies have observed that plasma total testosterone concentrations increased to a statistically significant degree in healthy men and certain patient populations following hyperbaric oxygen therapy.[15]

These findings provide preliminary clinical data supporting the hypothesis that hyperbaric oxygen may help support endogenous testosterone synthesis. They are also consistent with the mitochondrial energy mechanisms discussed above.

Observation B: Neutral Findings

Scientific integrity also requires equal attention to conflicting or neutral evidence.

Other studies involving patients with erectile dysfunction have shown that HBOT significantly improved International Index of Erectile Function–Erectile Function domain scores, or IIEF-EF scores, indicating an objective improvement in erectile function. However, within these specific study populations, neither total testosterone nor free testosterone levels changed significantly before and after treatment.[16]

This finding is highly informative. It suggests that improvements in erectile function associated with HBOT may occur primarily through the vascular–endothelial pathway described in Mechanism 3, rather than necessarily depending on a direct increase in testosterone levels.[14,16]

Overall Perspective

Based on both groups of observations, this article reaches a cautious and neutral conclusion:

Hyperbaric oxygen therapy is not a “miracle treatment” that can replace exogenous testosterone supplementation. Existing evidence is insufficient to support the strong claim that HBOT can reliably and universally increase testosterone levels in all populations.[15–17]

However, as a systemic method of supporting vascular health and cellular energy metabolism, hyperbaric oxygen therapy has demonstrated noteworthy adjunctive potential in improving overall microcirculation, relieving tissue hypoxia, and optimizing the endocrine microenvironment.[9–11] Its value should be understood as helping create more favorable conditions for the body’s own synthetic capacity, rather than directly replacing hormones.

Differences between study findings may be related to variations in participants’ baseline conditions, treatment pressure, inhaled oxygen concentration, treatment duration, and session frequency. This leads directly to the technical discussion in the following section.[15–17]

Technical Practice Reference for Clinics and Practitioners

The following information does not constitute treatment advice. It is presented as a technical protocol reference based on existing research literature and biohacking practices. Any practical application must be evaluated by a qualified medical or health professional.

1. Pressure Range and Oxygen Delivery Configuration

In endocrine wellness and broader anti-aging applications, existing research and wellness-center practices commonly favor mild hyperbaric oxygen therapy at 1.3 ATA to 1.5 ATA, combined with high-concentration oxygen inhalation.[9,18,19]

The rationale behind this configuration is one of balance:

• Synergistic dissolved-oxygen efficiency: As discussed in Mechanism 1, pressure at 1.3–1.5 ATA must be combined with high-concentration oxygen inhalation through a mask to produce a meaningful increase in dissolved oxygen. Neither element can create the same effect independently.[9,18]
• Safety and tolerability: Compared with clinical hyperbaric protocols at 2.0–2.8 ATA for conditions such as decompression sickness and gas gangrene, mild hyperbaric oxygen may substantially reduce the risks of oxygen toxicity and barotrauma, making it more suitable for long-term, periodic wellness applications.[9,18]
• Hormetic window: Mild pressure may fall within a range of beneficial stress that encourages antioxidant adaptation rather than oxidative overload.[10,11,19]

2. Protocol Frequency and Duration

Given the importance of intermittent exposure described in Mechanism 2 and the fact that angiogenesis is a biological process requiring cumulative time, short-term or sporadic exposure is unlikely to produce structural changes.[9–11]

Commonly used protocol parameters in current practice include:

• Frequency: Three to five sessions per week;
• Session duration: 60–90 minutes, followed by a return to normoxic conditions to maintain the intermittent hyperoxic-hypoxic rhythm;
• Total course: Several weeks or longer, allowing sufficient time for microvascular remodeling, mitochondrial adaptation, and upregulation of antioxidant systems.[10,18,19]

The key lies in combining periodicity, intermittency, and continuity. The cumulative effects of physiological adaptation may be more meaningful than the immediate response to a single exposure.[10,11]

Technical Support Statement

Technical Context

As a professional manufacturer committed to the advancement of non-clinical hyperbaric technologies, Oxy-Boss designs and engineers chambers with precision pressure control ranging from 1.3 to 1.5 ATA and integrated high-concentration oxygen delivery systems to support the research and practice of wellness centers and distributors worldwide. For technical specifications or to discuss custom OEM setups for your business, please contact our engineering team.

As a professional manufacturer committed to advancing non-clinical hyperbaric technologies, OxyBoss designs and manufactures hyperbaric chambers with precise pressure control capabilities ranging from 1.3 to 1.5 ATA, together with integrated high-concentration oxygen delivery systems. These systems are intended to support the research and practical work of wellness centers and distributors worldwide.

For detailed technical specifications or to discuss a customized OEM solution for your business, please contact our engineering team.

Disclaimer: This article is a scientific literature review intended to summarize the current state of research concerning hyperbaric oxygen therapy and the male endocrine system. It does not constitute medical diagnosis, treatment advice, or a health claim. Any physiological effects discussed in this article must be evaluated under the guidance of a qualified medical professional. In most jurisdictions, hyperbaric oxygen therapy is a medical intervention approved for specific indications. Non-clinical applications must comply with applicable local laws and regulations.

References

1. Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: Longitudinal results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 2002;87(2):589–598. doi:10.1210/jcem.87.2.8201.
2. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR. Longitudinal effects of aging on serum total and free testosterone levels in healthy men: Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab. 2001;86(2):724–731. doi:10.1210/jcem.86.2.7219.
3. Wang Y, Chen F, Ye L, Zirkin B, Chen H. Steroidogenesis in Leydig cells: Effects of aging and environmental factors. Reproduction. 2017;154(4)–R122. doi:10.1530/REP-17-0064.
4. Zirkin BR, Papadopoulos V. Leydig cells: Formation, function, and regulation. Biol Reprod. 2018;99(1):101–111. doi:10.1093/biolre/ioy059.
5. Wang X, Pan L, Zou Z, Wang D, Lu Y, Dong Z, et al. Hypoxia reduces testosterone synthesis in mouse Leydig cells by inhibiting NRF1-activated StAR expression. Oncotarget. 2017;8(10):16401–16413. doi:10.18632/oncotarget.14842.
6. Wang X, Zou Z, Yang Z, Jiang S, Lu Y, Wang D, et al. HIF 1 inhibits STAR transcription and testosterone synthesis in murine Leydig cells. J Mol Endocrinol. 2019;62(1):1–13. doi:10.1530/JME-18-0148.
7. Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, et al. Testosterone therapy in men with hypogonadism: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715–1744. doi:10.1210/jc.2018-00229.
8. Stocco DM. StAR protein and the regulation of steroid hormone biosynthesis. Annu Rev Physiol. 2001;63:193–213. doi:10.1146/annurev.physiol.63.1.193.
9. Thom SR. Hyperbaric oxygen: Its mechanisms and efficacy. Plast Reconstr Surg. 2011;127 Suppl 1:131S–141S. doi:10.1097/PRS.0b013e3181fbe2bf.
10. Hadanny A, Efrati S. The hyperoxic-hypoxic paradox. Biomolecules. 2020;10(6):958. doi:10.3390/biom10060958.
11. De Wolde SD, Hulskes RH, Weenink RP, Hollmann MW, van Hulst RA. The effects of hyperbaric oxygenation on oxidative stress, inflammation and angiogenesis. Biomolecules. 2021;11(8):1210. doi:10.3390/biom11081210.
12. Harabin AL, Braisted JC, Flynn ET. Response of antioxidant enzymes to intermittent and continuous hyperbaric oxygen. J Appl Physiol. 1990;69(1):328–335. doi:10.1152/jappl.1990.69.1.328.
13. Boykin JV Jr, Baylis C. Hyperbaric oxygen therapy mediates increased nitric oxide production associated with wound healing: A preliminary study. Adv Skin Wound Care. 2007;20(7):382–388. doi:10.1097/01.ASW.0000280198.81130.d5.
14. Hadanny A, Lang E, Copel L, Meir O, Bechor Y, Fishlev G, et al. Hyperbaric oxygen can induce angiogenesis and recover erectile function. Int J Impot Res. 2018;30(6):292–299. doi:10.1038/s41443-018-0023-9.
15. Passavanti G, Tanasi P, Brauzzi M, Pagni MR, Norgini E, Aloisi AM. Can hyperbaric oxygenation therapy modify the blood testosterone concentration? Urologia. 2010;77(1):52–56. doi:10.1177/039156031007700109.
16. Sen V, Sahin MO, Irer B, Koc E, Yildiz G. The impact of hyperbaric oxygen therapy on erectile functions and serum testosterone levels in patients with erectile dysfunction. Aging Male. 2020;23(1):66–70. doi:10.1080/13685538.2019.1578740.
17. Branco BHM, Fukuda DH, Andreato LV, Santos JFS, Esteves JVC, et al. The effects of hyperbaric oxygen therapy on post-training recovery in jiu-jitsu athletes. PLoS One. 2016;11(3). doi:10.1371/journal.pone.0150517.
18. Ortega MA, Fraile-Martinez O, García-Montero C, Callejón-Peláez E, Sáez MA, Álvarez-Mon MA, et al. A general overview on the hyperbaric oxygen therapy: Applications, mechanisms and translational opportunities. Medicina. 2021;57(9):864. doi:10.3390/medicina57090864.
19. Fu Q, Duan R, Sun Y, Li Q. Hyperbaric oxygen therapy for healthy aging: From mechanisms to therapeutics. Redox Biol. 2022;53:102352. doi:10.1016/j.redox.2022.102352.